| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 53,370 | 17,040 | 8,630 | 10,680 | 2,360 |
| Sales Growth | +213.20% | +97.45% | -19.19% | +352.54% | -90.51% |
| Net Income | -38,000 | -16,180 | 183,980 | 17,960 | 28,210 |
| Net Income Growth | -134.86% | -108.79% | +924.39% | -36.33% | +182.01% |
Westaim Corp (WEDXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
The Westaim Corporation is a technology accelerator that ensures its technology investments have the leadership, strategy, and capital to get into the marketplace as quickly as possible. Currently, Westaim has technology investments in three of the most important and fastest growing sectors of the economy: biomedical (Westaim Biomedical Corp.), semi-conductor/electronics (iFire Technology Inc.), and e-business software (Savvion).
Fiscal Year End Date: 12/31